LivaNova (LIVN) Non-Current Deferred Tax Liability (2015 - 2026)
LivaNova (LIVN) posted Non-Current Deferred Tax Liability of $6.8 million for Q1 2026, down 28.97% sequentially from $9.6 million in Q4 2025, and down 35.89% YoY from $10.6 million in Q1 2025.
LivaNova (LIVN) Non-Current Deferred Tax Liability (2015 - 2026) Analysis & Trends
LivaNova has reported Non-Current Deferred Tax Liability for 12 years, with the latest figure at $6.8 million in Q1 2026.
- Quarterly Non-Current Deferred Tax Liability fell 35.89% year-over-year to $6.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.8 million (down 35.89% YoY) and the FY2025 annual result came in at $9.6 million, down 85.25% from the prior year.
- Non-Current Deferred Tax Liability eased to $6.8 million in Q1 2026 per LIVN's latest filing, from $9.6 million in the prior quarter.
- Over five years, Non-Current Deferred Tax Liability peaked at $89.2 million in Q4 2022 and troughed at $6.5 million in Q3 2022.
- A 5-year average of $20.5 million and a median of $10.1 million in 2025 frame the typical range for Non-Current Deferred Tax Liability.
- The sharpest annual moves came in 2022 and 2025: Non-Current Deferred Tax Liability surged 1054.62% in 2022, then tumbled 85.25% in 2025.
- Over 5 years, Non-Current Deferred Tax Liability stood at $89.2 million in 2022, then tumbled by 30.34% to $62.2 million in 2023, then grew by 4.62% to $65.0 million in 2024, then sank by 85.25% to $9.6 million in 2025, then decreased by 28.97% to $6.8 million in 2026.
- According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $6.8 million, $9.6 million, and $10.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.91 Bn | 193.31 Bn | 7.27 Bn |
| 2 | Stryker | 127.59 Bn | 124.11 Bn | 4.50 Bn |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.24 Bn | 72.70 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn |
| 6 | Dexcom | 34.38 Bn | 32.44 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.96 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn |
| 9 | Steris | 23.08 Bn | 22.60 Bn | 684.20 Mn |
| 10 | LivaNova | 4.29 Bn | 3.77 Bn | 273.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.31 Mn |
| Jun 30, 2026 | 9.31 Mn |
| Mar 31, 2026 | 6.81 Mn |
| Mar 31, 2026 | 6.81 Mn |
| Dec 31, 2025 | 9.59 Mn |
| Dec 31, 2025 | 9.59 Mn |
| Sep 30, 2025 | 10.10 Mn |
| Sep 30, 2025 | 10.10 Mn |
| Jun 30, 2025 | 11.39 Mn |
| Jun 30, 2025 | 11.39 Mn |
| Mar 31, 2025 | 10.63 Mn |
| Mar 31, 2025 | 10.63 Mn |
| Dec 31, 2024 | 65.03 Mn |
| Dec 31, 2024 | 65.03 Mn |
| Sep 30, 2024 | 11.84 Mn |
| Sep 30, 2024 | 11.84 Mn |
| Jun 30, 2024 | 10.84 Mn |
| Jun 30, 2024 | 10.84 Mn |
| Mar 31, 2024 | 10.97 Mn |
| Mar 31, 2024 | 10.97 Mn |